Introduction
============

Gene duplication is a major force of evolution and plays a critical role in increasing complexity, and two rounds of whole genome duplication (WGD) have been proposed to occur during vertebrate evolution [@B1]. Duplicated genes may adopt three major modes of evolutionary divergence: loss by deleterious mutations (nonfunctionalization), acquisition of a new adaptive function (neofunctionalization) or division of an ancestral function (subfunctionalization). The role of gene duplication in evolution is perhaps best illustrated by the growth hormone (GH)-prolactin (PRL) family [@B2]. This family consists of GH, PRL, somatolactin (SL) and placental lactogen (PL), which has arisen from a single ancestor by gene duplication followed by extensive functional divergence. Although GH retains the original role in growth control in all vertebrate species, the other members have distinctive functions between fish and mammals: PRL is important for the mammary gland in mammals but for osmoregulation in fish [@B3], SL is fish-specific and selectively regulates proliferation and morphogenesis of pigment cells [@B4], and PL is specific to mammals and essential for placental development. They also exhibit differences in expression pattern: GH, PRL and SL retain the pituitary expression, whereas PL expression occurs in the placenta.

Fish models provide an ideal system to study the modes and mechanisms of duplicated genes\' evolution in vertebrates. After split from the tetrapod lineage, fish has undergone a third WGD event in the common ancestor of all modern-day teleosts [@B5]. Interestingly, the resultant genome-wide gene duplicates usually coexist, leading to more genes in fish [@B6]. The duplication-degeneration-complementation (DDC) mode was originally proposed in zebrafish to explain the preservation of duplicated genes: Duplicated genes undergo partial and complementary retention and degeneration to perform complementary functions that jointly match the function of a single ancestral gene [@B7]. This DDC mode emphasizes that complementary mutations in the regulatory sequences of gene duplicates lead to the retention rather than the loss of gene duplicates following WGD [@B7].

Fishes are the most diversified group of vertebrates and comprise 32,400 known species (as of Feb 6^th^, 2013 at <http://fishbase.mnhn.fr/search.php>). The enormous species diversity and presence of numerous gene duplicates make fishes an excellent system for studying gene evolution. It will be no surprising that diverse species may use other modes besides subfunctionalization. Neofunctionalization has recently been reported for the evolution of an antifreeze protein under escape from adaptive conflict in an antarctic zoarcid fish [@B8]. In the case of neofunctionalization, one of the duplicated genes must retain the original expression and function, and the other undergoes degeneration in expression and/or sequence to acquire an emerging new function. Therefore, the duplication-conservation-degeneration (DCD) may represent a transitory status from gene redundancy to neofunctionalization. The DCD mode is elusive to study, because it is often difficult to determine whether a gene under degeneration is indeed a degenerating gene: its remnant expression and/or activity could obscure observation and experimentation. Consequently, compelling evidence for the DCD mode has been absent, and the mechanism underlying this mode has remained poorly understood.

External coloration in animals including fish is a distinctive character for ornamental industry and evolutionary biology [@B9]. The body coloration is controlled by the development and patterning of pigment cells. Genes involved in fish pigmentation is of special interest to study the mechanisms underlying the evolution of duplicated genes in various species[@B10]. One such gene is *mitf* encoding microphthalmia-associated transcription factor (Mitf), a member of the basic helix-loop-helix leucine zipper (bHLH-Zip) protein family [@B11],[@B12]. Mitf plays a critical role in the development of melanocytes and retinal pigment epithelium (RPE) [@B13]-[@B16] and in human pigment diseases [@B17],[@B18].

In mammals, a single*mitf*gene produces multiple isoforms by differential usage of alternative promoters and exons [@B15],[@B19]-[@B21]. In fish, a genomic approach has been evolved to produce two Mitf proteins corresponding to the mouse MitfA and MitfM [@B22],[@B23]. Through the ancient WGD in the fish lineage 450 million years ago [@B24], many fish species have two distinct genes that are homologous/paralogous to single copy genes in tetrapod vertebrates including mammals and birds. In fish, *mitf* has been identified in \~40 species, and the presence of two *mitf* genes has been documented in several model fish species including fugu, pufferfish, *Xiphophorus*[@B22] and zebrafish [@B25],[@B26]. However, there is the lack of a nomenclature system for fish *mitf* genes. As a result, fish *mitf* genes have been named as *mitfa, mitfb, mitfm, mitf1* and *mitf2* on the basis of sequence homology and/or N-terminus. For example, the two zebrafish *mitf* genes are called *mitfa* and *mitfb*, with their protein products corresponding to the mouse MitfM and MitfA isoforms [@B25],[@B26]. A *mitfa* mutation called *nacre* affects the development of pigment cells on the skin but not in the eye, leading to cutaneous albinism [@B26], whereas *mitfb*, which is mainly expressed in the eye, provides necessary function for RPE development in the absence of *mitfa* activity [@B25]. Interestingly, ectopic expression of *mitfb* can rescue the pigment phenotype of *mitfa*mutant [@B25],[@B26]. Therefore, in zebrafish, the two *mitf* genes have undergone subfunctionalization to provide complementary expression patterns and functions in pigmentation [@B22],[@B25].

Medaka (*Oryzias latipes*) is a fish model to study pigment cell biology and the evolution of duplicated*mitf* genes in fish. This small laboratory fish is an excellent lower vertebrate model for analyzing development [@B27] and pigmentation biology. In this organism, there are more than 40 inbred lines and mutant strains showing diverse pigmentation patterns and abnormalities [@B28]. In fact, medaka has been the first teleost from which the tyrosinase gene was identified as the first fish gene involved in pigmentation [@B29]. In addition, medaka is a unique lower vertebrate that has male germ stem cells [@B30], diploid [@B31],[@B32] and even haploid embryonic stem (ES) cell lines [@B33] for studying pigment cell development in vitro. For example, we and others have previously demonstrated that forced expression of a heterologous *mitf* gene from *Xiphophorus* is sufficient for directing differentiation into melanocytes from medaka ES cell [@B34] and germ stem cells [@B35]. The medaka genome has been fully sequenced [@B36] and increasingly annotated (<http://www.ensembl.org/index.html>).

Here we show that medaka has two *mitf*genes, *mitf1*and*mitf2*, which encode Mitf1 and Mitf2 that correspond to the mouse MitfA and MitfM, respectively, on the basis of gene structure, chromosome synteny and phylogenetic sequence comparisons. We analyzed the embryonic and adult expression patterns of the *mitf* duplicate by RT-PCR and *in situ* hybridization, and determined the pigmentary activity of Mitf2 by reporter assay, real-time PCR analysis and melanocyte induction. We propose that medaka uses the DCD mode for evolution of its duplicated *mitf* genes through differential retention or loss of melanocytic expression in developing embryos.

Results
=======

Medaka Mitf1 and Mitf2 correspond to mammalian MitfA and MitfM
--------------------------------------------------------------

The sequenced medaka genome has two annotated *mitf*genes called *mitf1*and *mitf2*(<http://www.ensembl.org>). We followed this annotated gene nomenclature. The sequence appears to be partial for *mitf1* and complete for *mitf2*. A sequence comparison led to a putative full length of open reading frame (ORF) for *mitf1*. Cloning and sequencing led to the full length cDNA sequences for *mitf1* and *mitf2*, which predict proteins Mitf1 and Mitf2 of 512 and 406 amino acid residues, respectively ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Figure S1). On a sequence alignment, both medaka Mitf proteins are highly similar to the known Mitf homologues from other fish species and human ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Figure S2).

A single gene in birds and mammals produces multiple Mitf isoforms with distinct N-terminal sequences. Two major isoforms are MitfA and MitfM, which in human have 118 and 11 amino acids in the N-terminus, respectively (see below). Together with a comparison in protein domain structure, the medaka Mitf1 corresponds to the human isoform MitfA, and the Mitf2 is equivalent to the human MitfM (Figure [1](#F1){ref-type="fig"}A). Therefore, the two major fish Mitf proteins encoded by two distinct genes resemble the two major Mitf isoforms encoded by a single gene in higher vertebrates.

So far the fish *mitf* genes and their protein products have controversially been named in the literature. For example, fish genes whose protein products are similar to the mammalian MitfM isoform have been called *mitfa*in zebrafish, fugu and tetraodon or *mitfm* in *Xiphophorus*, whereas those whose protein products are similar to the mammalian MitfA isoform have been referred to as*mitf1*or*mitfb* [@B22],[@B25],[@B37]. All the five sequenced genomes of fish species, namely zebrafish, medaka, fugu, tetradon and stickleback, contain two separate *mitf* genes. The gene pairs are annotated as *mitf1* and *mitf2* in both medaka and stickleback (<http://www.ensembl.org/>), which were followed in this study. On the basis of protein domain structure, fish Mitf1 and Mitf2 proteins are more similar to the mammalian MitfA and MitfM, respectively. Hence, *mitfa* or *mitfm* genes previously described in other fish species are equivalents of the medaka *mitf2* gene, and previous *mitfb* genes correspond to the medaka *mitf1*. In this regard, the annotated stickleback Mitf1 and Mitf2 appears to be equivalents of medaka Mitf2 and Mitf1, respectively (Figure [1](#F1){ref-type="fig"}B). Designation of fish *mitf*genes as *mitf1* and *mitf2* will allows to similarly nomenclature fish Mitf isoforms, a salient feature of the *mitf* gene as has been demonstrated in mammals [@B38],[@B39].

By using an invertebrate Mitf protein from *Drosophila* [@B40] as the out-group, phylogenetic trees were constructed on the basis of amino acid sequences. In the phylogenetic tree constructed by using the neighbor-joining algorithm on the DNAMAN package, all vertebrate Mitf proteins fall into two major clades. One clade consists of fish Mitf2 proteins only, and the other comprises fish Mitf1 proteins and all mammalian Mitf proteins, as represented by the human MitfA and MitfM isoforms (Figure [1](#F1){ref-type="fig"}B). However, fish Mitf2 but not Mitf1 proteins may clustered with tetrapod counterparts on phylogenetic trees constructed by the maximum likelihood ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Figure S3) and minimum evolution methods ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Figure S4). In either case, the cross-species Mitf1 sequence similarity is generally higher than within-species comparisons between Mitf protein pairs in the fish species, suggesting that fish *mitf* duplicates may have shared an ancient WGD event in the common ancestor.

Medaka Mitf1 and Mitf2 differ in sequence divergence rate
---------------------------------------------------------

A total of \~40 fish Mitf sequences are available in public databases (<http://www.ncbi.nlm.nih.gov>; <http://www.ensembl.org>). This allowed us to compare the sequence divergence of Mitf duplicates in various fish species by using tetrapod Mitf proteins as a reference (Table [1](#T1){ref-type="table"}). Seven Mitf pairs of representative species fall into two categories. The first include *Xiphophorus*, fugu, two cichlid species and zebrafish and exhibits an apparent difference of 6% in sequence divergence between Mitf1 and Mitf2: On average, the 5 Mitf1 proteins are 73.5% identical to the tetrapod Mitf proteins, whereas this value decreases to 67.6% for the 5 Mitf2 proteins (Table [1](#T1){ref-type="table"}). Medaka also belongs to this category but represents an extreme. Notably, the medaka Mitf1 is 72.2% similar to the tetrapod reference. However, this value for the medaka Mitf2 sharply declines to 60.2%, leading to a difference of up to 12% between the medaka Mitf1 and Mitf2 (Table [1](#T1){ref-type="table"}). The second category is represented by stickleback, in which Mitf1 and Mitf2 display 67.1\~69.7% and 67.6\~72% identity to the tetrapod reference, respectively, and thus a similar rate of sequence divergence. Taken together, medaka Mitf1 exhibits a slower, and perhaps basal, evolutionary rate of change, whereas Mitf2 shows a significant acceleration in divergence rate.

Medaka *mitf1* and *mitf2* genes are the products of WGD
--------------------------------------------------------

Comparisons of chromosome locations revealed clear syntenic relationships between the *mitf*-bearing regions of human chromosome 3 and those of fish chromosome pairs, chromosomes 5 and 7 in medaka, and chromosomes 6 and 23 in zebrafish, respectively (Figure [2](#F2){ref-type="fig"}). These data strongly suggest that the presence of *mitf* gene pairs in diverse fish species is the consequence of WGD, which has been dated \~450 million years ago [@B5],[@B41],[@B42]. The chromosome syntenic relationship also demonstrates that the medaka *mitf1* and *mitf2* are co-homolog of the human *Mitf* gene.

Medaka *mitf1* and *mitf2* differ in the level of expression
------------------------------------------------------------

In mammals, a single *mitf* gene shows differential expression from alternative promoters and exons, and thereby producing multiple isoforms [@B15],[@B19]-[@B21]. We performed RT-PCR analysis to examine *mitf* expression (Figure [3](#F3){ref-type="fig"}A). In adult tissues, the transcripts of both genes were detected in all samples examined, including the ectodermal skin, brain and eye, mesodermal muscle, heart, kidney and spleen, endodermal liver and gut, and male and female gonads (testis and ovary). There was no apparent difference between *mitf1* and *mitf2* in a ubiquitous adult expression pattern. However, the level of *mitf2* expression appeared to be substantially lower than *mitf1*. After 36 cycles of PCR, *mitf1* was easily detectable (Figure [3](#F3){ref-type="fig"}A), whereas *mitf2* was barely detectable (data not shown). *mitf2*became detectable only after 40 cycles (Figure [3](#F3){ref-type="fig"}A). In developing embryos, the transcripts of *mitf1* and *mitf2* were detected as early as 2-cell stage (Figure [3](#F3){ref-type="fig"}A), suggesting their maternal inheritance. The expression of *mitf1* and *mitf2* occurs throughout embryogenesis. Notably, the RNA is clearly more abundant for *mitf1* than for *mitf2*also in developing embryos. Real-time RT-PCR analyses (Figure [3](#F3){ref-type="fig"}B) revealed that the *mitf1* RNA was more abundant than *mitf2* by 3 and 8 fold in the adult skin and eye, and 3 and 2 fold at embryonic stages 16 and 25, respectively. However, at the 4-cell stage, the *mitf2* RNA was more abundant than *mitf1* by 5 fold. Taken together, *mitf1* and *mitf2* show different levels of RNA expression in embryogenesis and adult tissues.

Medaka *mitf1* retains and *mitf2* loses melanocytic expression in embryos
--------------------------------------------------------------------------

To study the expression patterns of the medaka *mitf1* and *mitf2* in more detail, we performed *in situ* hybridization (ISH) in developing embryos at stage 29 (3 days post fertilization; dpf) [@B43], when pigment cells from the neural crest are clearly visible on the body and yolk sac, and pigmented RPE is evident in the eye [@B44]. To prevent black pigmentation in melanocytes, we treated embryos with phenylthiourea and used them for ISH. We made use of the *tyr* transcript as a melanocyte marker, which encodes tyrosinase, the key enzyme for melanin synthesis in maturing/mature melanocytes [@B29], In stage-29 embryos, *tyr*-positive cells were found as individual cells on the embryonic body, yolk sac and in RPE (Figure [3](#F3){ref-type="fig"}C). We found that *mitf1* exhibited a similar expression pattern (Figure [3](#F3){ref-type="fig"}D). However, *mitf2* expression was barely detectable at this stage (Figure [3](#F3){ref-type="fig"}E). Taken together, the medaka *mitf1* resembles the mouse *mitfm* in predominant expression in the pigment lineage, whereas the medaka *mitf2* did degenerate its expression in embryonic melanocytes. This suggests that medaka *mitf1* but not *mitf2* might be a major player for embryonic melanocytes at this critical stage.

We then performed fluorescence ISH to examine the adult expression on cross-sections of the posterior trunk. Both genes exhibited a ubiquitous expression in a wide variety of tissues, including the skin, muscle, neural tube and vertebra (Figure [3](#F3){ref-type="fig"}F and G). We noticed that the *mitf2*signal was relatively stronger than *mitf1*in the spinal cord and muscle. Hence, *mitf1* and *mitf2* show a generally overlapping expression pattern in adult tissues.

Medaka Mitf2 possesses a reduced melanogenic activity
-----------------------------------------------------

Mitf controls pigmentation through two distinct aspects: One is to activate the expression of enzymes (e.g. tyrosinase) involved in melanin synthesis (melanogenesis) and in maturing/mature melanocytes and the other is to regulate melanocyte formation. The observation that the medaka *mitf2* exhibits an accelerated sequence divergence rate and a lower level of expression provokes us to examine whether this gene has maintained activity. To perform transfection experiments in medaka ES cell line MES1, which is capable of directed melanocyte differentiation following transfection by pXmitf that expresses the *Xiphophorus mitfm*[@B34], we constructed several expression vectors (Figure [4](#F4){ref-type="fig"}A). pTYRluc contains the 3.3-kb medaka tyrosinase gene promoter (TYR) ahead of the luciferase [@B45], and pOmitf2 constitutively expresses the medaka *mitf2* cDNA. In undifferentiated MES1 cells, *mitf* expression is not detectable by RT-PCR analysis [@B33], but can be activated by forced XmitfM expression [@B34]. Transfection with pTYRluc alone or together with pCVpf as a control led to a low reporter activity, which was 6 times that of transfection with pTAluc that contains a TATA-box minimal promoter. When pOmitf2 was used for cotransfection with pTYRluc, a 6.5-fold increase in luciferase activity was observed (Figure [4](#F4){ref-type="fig"}B), demonstrating that the medaka Mitf2 maintains melanogenic activity. However, when pXmitf was used for cotransfection, an increase by up to 178 fold was obtained (Figure [4](#F4){ref-type="fig"}B). Therefore, the melanogenic activity of the medaka Mitf2 is reduced by 27 fold compared to the *Xiphophorus* Mitf2. We then examined the induction of endogenous *tyr* expression by ectopic *mitf* expression in MES1 cells. Upon transfection with pOmitf2 and pXmitf, the *tyr* RNA expression was increased by 38 and 355 fold, respectively (Figure [4](#F4){ref-type="fig"}C). Compared to the *Xiphophorus* Mitf2, the medaka Mitf2 displays a 9.3-fold reduction in its activity to induce the endogenous *tyr* expression. Taken together, the medaka *mitf2* retains melanogenic activity that has considerably been degenerated compared to the X*mitf*.

Medaka Mitf2 possesses a reduced melanocyte-inducing activity
-------------------------------------------------------------

We then addressed whether the medaka Mitf2 possessed melanocyte-inducing activity, the original function of the prototype mouse MitfM. To this end, we took the advantage of an in vitro system for melanocyte induction again by using the medaka ES cell line MES1, in which X*mitf* expression is sufficient to direct melanocyte differentiation [@B34]. When pOmitf2 was used for transfection, 25 melanocytes were formed per well of a 12-well plate. This number increased to 1298 for pXmitf transfection (Figure [4](#F4){ref-type="fig"}D). This difference by 52 fold is not ascribed to variations in transfection efficiency, because many GFP-positive transgenic cells following pOmitf2 transfection did not become melanocytes, whereas the majority of GFP-positive cells following pXmitf transfection did (Figure [4](#F4){ref-type="fig"}E). Convincingly, the medaka Mitf2 possesses a reduced activity for melanocyte induction in vitro compared to the *Xiphophorus* counterpart.

In summary, the medaka *mitf* duplicates adopt two distinct directions of evolution: While *mitf1* displays conservation, *mitf2* shows significant degeneration in protein sequence, expression and activity.

Discussion
==========

We have recently identified Mitf as a transcriptional activator of medaka germ genes *in vitro* [@B46], and both *mitf1* and *mitf2* mRNAs as the component of the Balbiani body [@B47], a structure resembling germ plasm that exists transient in growing oocytes [@B48]. In this study, we have identified the medaka *mitf1* and *mitf2* gene duplicate as the co-homologs of the mouse *mitf*. Strikingly, the medaka *mitf1* retains expression in the embryonic pigmentary lineage including both melanocytes and RPE, in which the medaka *mitf2* lacks detectable expression. We propose that medaka makes use of the DCD mode for the evolution of duplicated *mitf* genes: In the developing embryo, *mitf1* has retained the original melanocytic expression and perform the ancestral *mitf* function, whereas *mitf2* has undergone degeneration to such a degree that its melanocytic expression becomes hardly detectable at the critical stages. In contrast, zebrafish utilizes the DDC mode for the evolution of its duplicated *mitf* genes, where both genes have undergone partial retention and degeneration to jointly display complementary expression and thus execute complementary subfunctions of a single ancestral *mitf* in both melanocytes and RPE. Whether *mitf2* degeneration is towards neofunctionalization or nonfunctionalization remains open.

Concurrent retention and loss of expression in the embryonic pigmentary lineage is a key feature of the DCD mode. Since various cell lineages are formed during embryogenesis, loss of expression at critical stages of embryogenesis may exclude an essential role for the degenerating *mitf2* in the pigment lineage establishment. Notably, the *mitf2* (also named *mitfa*) promoter can drive transgene expression in adult pigment cells [@B49].

Besides the loss of expression in the embryonic pigmentary lineage, the medaka *mitf2* also shows an expression level that is much lower than the conserved *mitf1* in both embryos and adult tissues. We show that reduced *mitf2* expression is not compensated by increased melanocyte-inducing and melanogenic activity, but instead, accompanied by a remarkably degenerated melanogenic activity. These facts together with a higher divergence rate of the Mitf2 sequence strongly suggest that *mitf2* has already been released from the constraint for pigment development and is in a transitory status towards neofunctionalization or nonfunctionalization. The mouse *mitf* is also expressed in several non-pigmentary lineages in the form of various variants. A substantially lower expression level would imply that *mitf2* has degenerated its role to some extent also in non-pigmentary lineages. It deserves to note that in the case of medaka *mitf* gene pair, the DCD mode operates at multiple aspects, including sequence divergence rate, expression and activity of the protein product. It is unknown whether these aspects act independently or collectively.

Expression of the *Xiphophorus mitf* gene pair has been examined by RT-PCR analysis in adult tissues: *mitfb* shows ubiquitous expression, whereas *mitfm* is expressed only in the eye, skin and melanomas [@B22]. This suggests that the *Xiphophorus mitf* duplicates also adopt the DCD mode: *mitfm* has retained its pigmentary expression, whereas *mitfb* has acquired non-pigmentary expression in the adulthood. It is unknown whether the *mitf* genes also use the DCD mode during *Xiphophorus* embryogenesis.

To compare the relative protein activity, we have chosen the medaka Mitf2 and its *Xiphophorus* counterpart *Xmitf*, the latter being the only fish Mitf that has been studied both for expression *in vivo* [@B37] and activity *in vitro* [@B34]. This comparison has revealed a great reduction in the activity of the medaka Mitf2 protein product, consistent with its accelerated protein sequence divergence indicative of degeneration. An ideal situation is to include the medaka Mitf1 also in the experiment, which is, however, not practical, at the present. In contrast to the *mitf2* that produces only one form, the *mitf1* is able to produce multiple isoforms, which isoform is functionally equivalent to *mitf2*remains to be determined.

Our finding that the wide adult expression of medaka *mitf2* accompanies the retention of melanocyte-inducing activity by its protein product in combination with the fact that Mitf is a melanocyte master regulator raises an interesting question as to why many *mitf2*-expressing cells do not become melanocytes. A low level of expression and a dramatically reduced activity for melanocyte induction may account for an insufficient activity for melanocyte induction in non-pigment cells. This notion is supported by the fact that the expression of highly active X*mitf* is limited to the pigment cell-containing tissues in *Xiphophorus*[@B22]. It deserves to note that the medaka *mitf2* has been compared for melanogenic activity and melanocyte induction with the X*mitf* in this study. The medaka *mitf1* can produce multiple isoforms (data not shown). Future work will elucidate which isoform corresponds to the Mitf2 protein product to allow for a direct comparison between *mitf1* and *mitf2*.

Our observation that both *mitf1* and *mitf2* are maternal factors in medaka is intriguing, because in all other vertebrate species examined so far, the *mitf*gene does not show maternal inheritance and its expression does not commence until late stages of embryogenesis when the pigment cell lineage starts to develop. For example, zygotic *mitf* expression occurs at the 16-somite stage in zebrafish [@B25],[@B26], stage 21/22 in *Xenopus* [@B50], the 5-day-old embryo in chicken [@B51] and the 9.5-day-old embryo in mouse [@B52]. Interestingly, *mitf* maternal inheritance has been described in diverse invertebrate species such as *Drosophila*[@B40] and ascidians [@B53].

Our data illustrate that the *mitf* gene duplicates may adopt different ways of evolutionary divergence in different species. This species-specific difference has recently reported also to *tyrp1* encoding tyrosinase-related protein 1 (*Tyrp1*). In medaka embryos, *tyrp1a*expression occurs in the RPE and melanophores while *tyrp1b* is expressed only in melanophores. In zebrafish embryos, the duplicated *tyrp1*genes exhibit overlapping expression in the RPE and melanophores, and knockdown of both *tyrp1* genes leads to pigmentary defects [@B54]. In this case, medaka adopts the DCD mode, and zebrafish uses the DDC mode as usual. It will be interesting to determine whether non-pigmentary genes also exhibit such a species-specific difference in evolutionary divergence.

Approximately 30% of zebrafish genes are duplicates [@B5],[@B55], their current co-existence may well be explained by the DDC mode [@B7]. Evolution of many other gene duplicates must follow a different way, so that one copy can no longer be identified as a member of the gene pair. This copy may have undergone neofunctionalization or nonfunctionalization. During the past process of neofunctionalization or nonfunctionalization, the DCD mode must have operated. Therefore, the DCD mode used by the medaka *mitf* gene may represent an intermediate step for gene loss or neofunctionalization in the past, and towards gene loss or neofunctionalization in the future. During early stages of evolution, the DCD mode might be insufficiently distinguishable to the DDC mode because of remnant expression and/or function.

Methods
=======

Fish
----

Work with fish followed the guidelines on the Care and Use of Animals for Scientific Purposes of the National Advisory Committee for Laboratory Animal Research in Singapore (permit number 27/09). Medaka strains HB32C, orange, *i^1^* and *af* were maintained under an artificial photoperiod of 14-h/10-h light/darkness at 26°C as described [@B56]. Embryogenesis was staged according to the description [@B44].

Sequence Analysis
-----------------

Multiple sequence alignment was conducted by using the Vector NTI suite (version 11, Invitrogen). A phylogenetic tree was constructed by using the DNAMAN software (version 4.15, Lynnon Biosoft) from a matrix of pairwise genetic distances according to the neighbor-joining (NJ), maximum likelihood [@B57] and minimum evolution (ME) methods, and 1,000 trials of bootstrap analyses were used to provide confidence estimates for tree topologies. Genomic organization and chromosomal locations were investigated by comparing the cDNA and corresponding genomic sequence (<http://www.ensembl.org>).

Plasmids
--------

The medaka tyrosinase (*tyr*) cDNA is available (accession number NM_001104802) and annotated under ENSORLG00000004539. Putative medaka *mitf1* (ENSORLG00000013461) and *mitf2* (ENSORLG00000003123) are available in the genome sequence (<http://www.ensembl.org/index.html>). Their cDNA sequences were PCR-amplified from a cDNA library of 9-day-old embryos by using primer sets tyr882f (CGCTGACGTAGAGTTCACCAT) plus tyr1621R (TAGCCGTCATTGTGGCCAA) for *tyra*, GAATTCATGCAGTCCGAATCCGGAATAG plus ATCGATACAGCCCTGCTCGTTTTCATCCAT for *mitf1*, and ttgAGATCTGAATTCATGTTGGAGATGTTGGAATACAGC plus ttgATCGATACAGCCATTCTCTTTTTCCTCCATGC for *mitf2*. The PCR products were of 740 bp, 1230 bp and 1182 bp in length and cloned into pGEM-T, producing pGEMtyr, pGEMmi1 and pGEMmi2. Correct cloning was confirmed by sequencing.

Four luciferase [@B45] reporter plasmids were used in this study. pGL3-basic is promoterless and contains the firefly *luc* (Promega). pTAluc was derived by inserting the TATA-containing minimal promoter of the herpes simplex virus thymidine kinase upstream of *luc* in pGL3-basic. To construct pTYRluc, the 3.3-kb promoter of a medaka tyrosinase gene (tyra; accession number AB010101) was obtained by PCR from genomic DNA with primer TT[ACGCGT]{.ul}AGTGAGTGATGCACCTCTGC and T[CTCGAG]{.ul}ATTCACCCACATCTGTCC (restriction sites are underlined) and inserted between Mlu I and Xho I ahead of the *luc* in pGL3-Basic. pRL-CMV expresses the *Renilla* Luc and used as internal reference to calibrate transfection efficiency (Promega).

Two effector plasmids used were pXmitf (originally called pCMVTKmitf-M) expressing the *Xiphophorus mitf-M*[@B34] and pOmitf2 expressing the medaka *mitf2* , the latter being constructed by inserting the medaka *mitf2* cDNA in frame to the cherry sequence in pCS2+. In addition, pCVpf was constructed by inserting in frame the puromycin acetyltransferase gene to *gfp*in pEGFP-N1 (Clontech). These three plasmids use the human cytomegalovirus early enhancer/promoter (CV) to drive transgene expression.

RNA isolation and RT-PCR
------------------------

Total RNA from medaka embryos, adult tissues and cell culture was isolated by using the Trizol reagent (Invitrogen) and used for cDNA synthesis by using oligo(dT)~25~ and the MMLV reverse transcriptase (Invitrogen) as described [@B30]. PCR was performed by using primers GTAGATTACATCCGCAAGCTG and ACAGCCCTGCTCGTTTTCATCCAT for *mitf1*, AGCTCCTGTGCATCTGGCATT and GTTGAACCTTCGCCTTCGTT for *mitf2*. As a control, *β-actin* was amplified from the same set of cDNA samples using primers TTCAACAGCCCTGCCATGTAC and CCTCCAATCCAGACAGAGTATT. PCR was run for 30 cycles (*β-actin*) and 36 or 40 cycles (*mitf1*or*mitf2*) of 10 s at 94°C, 15 s at 58°C and 60 s at 72°C. The PCR products were separated on 1.0% agarose gels and documented with a bioimaging system (Synoptics, Cambridge, UK).

Real-time RT-PCR
----------------

Real-time PCR was performed with SYBR® Green qPCR SuperMix (Invitrogen) on the IQ5 real-time PCR detection system (BioRad). The primers for detecting were tyr1514F (TCACCATGCTTTCATTGACAGC) and tyr1621R for the medaka *tyra*, mitf1-QF (TCTCCTGCCATCATGCACA) and mitf1-QR (AGCGCTCTTACCTCAGCTTCA) for the medaka *mitf1,* mitf2-QF (CAACTTGATTGAACGAAGGCG) and mitf2-QR (TGTTCCAGCGCATATCTGGAT) for the medaka *mitf2*, actinqs (AGAAGAGCTATGAGCTGCCTG) and actinqr (AACATCACACTTCATGATGCTG) for the medaka *β-actin* as a loading control. The relative fold change of *tyr* quantities was calculated with 2(-delta delta Ct) method [@B58].

*In situ* hybridization
-----------------------

Antisense RNA probes were synthesized from linearized pGEMtyr, pGEMmi1 and pGEMmi2 by using the DIG RNA labeling kit [@B59] as described [@B60]. Embryos at stage 29 were subjected to *in situ* hybridization (ISH) with DIG-labeled probe followed by chromogenic staining with NBT/BCIP as described [@B61]. Sections were subjected to two-color fluorescence in situ hybridization [@B20] by using the tyramide signal amplification (TSA^TM^) Plus Fluorescence Systems according to the manufacturer\'s instruction (NEL756, PerkinElmer Life Science) as described [@B60]. Briefly, after hybridization and blocking as described above, the samples were incubated with the POD-conjugated anti-FITC-antibody (Sigma) at a 1:2000 dilution for 2 hours at room temperature to detect the FITC-labeled probes. Following six PBST washes the samples were incubated for 30 minutes in the TSA-Fluorecein at a 1:100 dilution in the TSA Amplification Buffer (0.004% H~2~O~2~ in 0.1 M borate buffer, pH8). The samples were then subjected to detection of the DIG-labeled probe: They were treated for 1 hour in 1% H~2~O~2~and incubated for two hours with the horseradish peroxidase (POD)-conjugated anti-DIG antibody (Sigma) at a 1:2000 dilution, followed by 30-min incubation in TSA-Cy3 for 30 min. The samples were finally stained for nuclei by using DAPI (µg/ml) and embedded in the Gold Antifade reagent (Invitrogen) for microscopy. In this FISH procedure, two differently labeled antisense RNA probes are co-incubated with a sample in the hybridization step and subjected to sequential color development into green and red fluorescence [@B62].

Cell culture and transfection
-----------------------------

Plasmid DNA was prepared by using the Qiagen Midi- and Maxi-preps kit (Qiagen). The medaka ES cell line MES1 was maintained on gelatin-coated tissue culture plastic ware in medium ESM4 containing 15% fetal bovine serum [@B63] and transfected as described [@B64]. In this cell line it has previously been shown that pXmitf transfection is sufficient to direct melanocyte differentiation [@B34]. Cells in 24-, 12- and 6-well plates were transfected with 0.5, 1 and 3 μg of plasmid DNA by using the Gene Juice reagent (Novagen) or the DNAfectin^TM^ 2200 with a ratio of 1 μg DNA to 4 μl of Gene Juice (Novagen) or the DNAfectin reagent (Applied Biological Materials Inc.) according to the manufacturers\' instructions. pCVpf was cotransfected with pOmitf2 or pXmitf at a 1:4 ratio. Control transfection received only pCVpf. Appearance of black pigmented melanocytes was monitored from day 3 post transfection (dpt) onwards. In some experiments, cell transfection was followed by drug selection to enrich for transgenic cells. For this, cells following cotransfection with pCVpf were grown in the presence of puromycin (final 1 μg/ml) for 2 days before harvest for RNA isolation and RT-PCR analysis.

Luciferase reporter assay
-------------------------

For reporter assays, cells were transfected in 96-well plates with modifications [@B46],[@B65],[@B66]. Briefly, \~30,000 cells were seeded in 96-well plates (Biostar) and transfected with 102 ng of plasmid DNA. The following day, cells were at \~70% of confluence and transfected. For cotransfection, plasmid DNA for each well of 96-well plate contains 2 ng of pRL-CMV as the internal reference, 50 ng of a firefly luciferase reporter (pGL3-basic, pTAluc or pTYRluc), 25 ng of pOmitf2 or pXmitf, and 25 ng of pCVpf. For control transfection, each well received 2 ng of pRL-CMV, 50 ng of a firefly luciferase reporter plasmid and 50 ng of pCVpf. Transfection efficiency was monitored by GFP expression from pCVpf in a duplicate 96-well plate to be at \~10% and \~30% for the Gene Juice and DNAfectin^TM^ 2200 reagents, respectively. At day 3 or 4 dpt, cells were measured for luciferase activity by using the Dual-Glo^TM^ Luciferase assay kit (Promega) and measured on Glomax^TM^ 96 Microplate Luminometer (Promega). Briefly, each well was replaced by 20 µl of fresh medium containing only 9% FBS. The plate was equilibrated at room temperature (RT) for 10 min. For measuring firefly luciferase activity, 20 µl of Dual-Glo™ Luciferase reagent was added to each well and mixed. After incubation at RT for 20 min, the firefly luminescence was measured in the Glomax^TM^ 96 Microplate Luminometer (Promega), Subsequently, 20 µl of Dual-Glo™ Stop & Glo® Reagent (1:100 dilution of substrate to buffer) was added to each well, mixed, incubated at RT for 10 min and measured similarly for the Renilla luciferase activity. The ratio between firefly luciferase activity and *Renilla*luciferase activity was used for comparisons. The reading from pGL3-basic was considered as background, and that from pTAluc treated as unit activity. Relative luciferase activity from pTYRluc alone or in combination with pOmitf2 or pXmitf was normalized to that of pTAluc.

Microscopy
----------

Microscopy was done as described [@B43]. Briefly, Cells were observed and photographed on Zeiss Axiovert2 invert microscope and Axiovert200 upright microscope equipped with a Zeiss AxioCam MRc digital camera and AxioVision 4 software, and embryos and fry were visualized using a Leica MZFLIII stereo microscope equipped with a Fluo III UV-light system and photographed by using a Nikon E4500 digital camera (Nikon Corp).
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mitf

:   microphthalmia-associated transcription factor

RPE

:   retinal pigment epithelium

WGD

:   whole genome duplication

dpt

:   day(s) post transfection

![**Phylogenetic comparisons.**(A) Schematic protein domain structure. Alternative exon 1 (1a, 1b and 1m) and common exons 2-9 are shown above the protein. Also shown are protein domains: AD, activation domain; CD, conserved domain; bHLH-Zip, basic helix-loop-helix leucine zipper domain; asterisk, phosphorylation site by MAPK; hash, phosphorylation site by GSK3β. (B) Phylogenetic tree by the NJ algorithm. The *Drosophila* Mitf serves as the out-group. Bootstrap values are given. Accession numbers follow organisms and original names of Mitf proteins.](ijbsv09p0496g01){#F1}

![**Fish *mitf1* and *mitf2* are co-homologs of the human Mitf by chromosome synteny.** Medaka and zebrafish are compared to human. Data are compiled from <http://www.ensembl.org/index.html>. Chr, chromosome; numerals in parentheses, chromosomal positions.](ijbsv09p0496g02){#F2}

![**RNA expression.** (A) RT-PCR analysis in adult tissues and embryos. The number of PCR cycles is given in parenthesis for each gene. (B) Real-time PCR analysis. β-actin was used as the control for data calibration. Data are means ±s.d (error bars) of five determinations. \*\*, *p* ≤ 0.01. (C-E) Chromogenic ISH with antisense riboprobes on whole mount embryos at stage 29. Melanocytes (asterisks) in the body, yolk sac (sc) and RPE are positive for *tyr* and *mitf1* but not *mitf2*. (F and G) Cross-section of the adult posterior trunk after two-color fluorescence ISH with *mitf1* (F) and *mitf2* (G) antisense riboprobes. df, dorsal fin; ms, muscle; nt, neural tube; sc, spinal cord; sk, skin; vt, vertebra. Scale bars, 100 µm.](ijbsv09p0496g03){#F3}

![**Medaka Mitf2 has a reduced activity.** MES1 cells were used for cotransfection and analyses. (A) Vectors. (B) Luciferase reporter assay. Each of reporter plasmids pGL3luc, pTAluc and pTYRluc in combination with pRLluc was cotransfected with effector plasmids pOmitf2 or pXmitf into MES1 cells, and Luc activity was determined at day 3 dpt. pRLluc was used as the internal control for calibration of different samples and transfection efficiencies. pGL3luc was used as the negative control, whose activity was considered as background. pTAluc was used as the standard for normalization, whose activity was defined as unit activity. Fold activity was obtained by compared to control cotransfection with pCVpf. Data are means ±s.d of three experiments with triplicates each. (C) Real-time RT-PCR analysis of induced endogenous *tyr* expression. Data are means ±s.d of five determinations each. (D) Melanocyte formation. Data are means ±s.d of triplicate determinations in 12-well plates. P values are given in (B-D). (E) Micrographs showing the number of melanocytes relative to the number of GFP-positive transgenic cells.](ijbsv09p0496g04){#F4}

###### 

Percentage Mitf sequence identities between fishes and tetrapods^1)^

  Fish Mitf (aa)          Tetrapod Mitf (aa)                                                    
  ----------------------- -------------------- ------------- ------ ------ ------ ------ ------ ------
  **Mitf1**               *Xiphophorus*        Mitfb (462)   72.6   73.5   70.9   71.2   73.1   72.6
  Fugu                    Mitf1(478)           73.7          72.8   71.6   69.6   71.9   70.1   
  *Maylandia callainos*   Mitfb (402)          77.4          77.1   76.1   74.7   77.8   76.0   
  *Maylandia zebra*       Mitfb (512)          75.1          73.9   72.7   70.7   74.5   72.7   
  Zebrafish               Mitfb (427)          74.6          75.8   73.0   72.3   73.6   72.4   
  Average                 74.7                 74.6          72.9   71.7   74.2   72.8          
  **73.5**                                                                                      
  **Medaka**              Mitf1 (523)          73.3          73.8   71.2   70.6   72.6   71.8   
  Average                 **72.2**                                                              
  stickleback             Mitf2 (493)          69.7          69.0   68.1   67.1   68.9   68.9   
  **Mitf2**               *Xiphophorus*        MitfM (402)   65.3   68.7   63.9   66.1   65.3   64.9
  Fugu                    Mitf2 (394)          66.9          70.6   65.7   67.9   66.4   66.0   
  *Maylandia callainos*   Mitfa (401)          68.5          71.4   66.8   69.0   68.2   67.9   
  *Maylandia zebra*       Mitfa (401)          68.2          71.1   66.5   68.7   67.9   67.6   
  Zebrafish               Mitfa (412)          67.8          71.5   65.6   67.8   68.0   67.7   
  Average                 67.3                 70.7          65.7   67.9   67.2   66.8          
  **67.6**                                                                                      
  **Medaka**              Mitf2 (406)          59.5          63.0   58.9   60.9   59.5   59.1   
  Average                 **60.2**                                                              
  stickleback             Mitf1 (404)          68.8          72.0   66.8   69.0   67.9   67.6   

**^1)^**For gene accession numbers see Figure [1](#F1){ref-type="fig"}B.
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